Paul_G._Allen_Frontiers_Group

Paul G. Allen Frontiers Group

Paul G. Allen Frontiers Group

Bioscience research initiative

The Paul G. Allen Frontiers Group is a Seattle-based bioscience research initiative started in 2016 and funded with an initial investment of $100 million.[1] It is a division of the Allen Institute.[2] Its vision is to identify areas in bioscience that are ripe for a major breakthrough, and then fund specific investigators to pursue advances.[3]

In 2021, the Allen Frontiers Group joined the Open Research Funders Group (ORFG).[4]

Allen Distinguished Investigators

The Distinguished Investigator program "awards grants of $1.5 million of three years in support of early-stage research in biology and medicine that would not otherwise be supported by traditional funding sources."[5]

References

  1. [1]
    Cha, Ariana Eunjung (2021-10-26). "Philanthropist Paul Allen announces $100 million gift to expand 'frontiers of bioscience'". Washington Post. ISSN 0190-8286. Retrieved 2023-11-07.
  2. [2]
    Savchuk, Katia. "Billionaire Paul Allen Pledges $100 Million To Fund Cutting-Edge Life Sciences Research". Forbes. Retrieved 2023-11-07.
  3. [3]
    "Microsoft pioneer invests big, again, in bioscience". Sciencemag.org. Retrieved March 24, 2016.
  4. [4]
    "Allen Frontiers Group Joins ORFG". Open Research Funders Group. 2021-09-29. Retrieved 2023-11-07.
  5. [5]
    "Frontiers Group announces 2021 Allen Distinguished Investigators". Philanthropynewsdigest.org.


This article about an organization in the United States is a stub. You can help Wikipedia by expanding it.

Stub icon

This article about a biology organization is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article Paul_G._Allen_Frontiers_Group, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.